MedTrace Logo

Clinical Pharmacist Impact Study

NCT07269002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3600

Last updated 2025-12-08

No results posted yet for this study

Summary

This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify potential medication issues and support therapeutic decision-making. The study was conducted in both adult and pediatric inpatients as part of routine clinical care. No investigational drugs or devices were used.

Conditions

  • Medication Safety
  • Preventable Medication Harm
  • Pharmacotherapy Optimization

Interventions

OTHER

Pharmacist-Led Medication Safety Program

A structured clinical pharmacist program that includes inpatient medication review, identification of potential medication-related problems, and use of smartphone-based clinical decision-support applications to support therapeutic decision-making and enhance medication safety practices.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-15
Primary Completion
2025-09-15
Completion
2025-09-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07269002 on ClinicalTrials.gov